Overview
Status
Active
Registry date
2015-07-01
Share capital
5,000.00 PLN
Registered address
ul. Aleksandra Fredry 9B/3, 78-100 Kołobrzeg, Poland
Electronic delivery address
AE:PL-52456-37513-HJAVS-39
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 216 days late).
- 202514/07/2026
- 202414/07/2025
- 202313/07/2024
- 202220/04/2023
- 202116/02/2023
- 202030/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 50.64kMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD -4.35kMedianUSD 20.66kAverageUSD 86.62k
Operating costs
This companyUSD 54.94kMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 257.11kMedianUSD 544.32kAverageUSD 1.76m
Industry
Authorized Representatives
Roma Magdalena Kowalkiewicz – President of the Management Board
Manner of representation
Each member of the management board is independently authorised to make declarations of will on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Igor Tomasz Kowalkiewicz | 23 | $621.29 | 46% |
Pola Alicja Kowalkiewicz | 23 | $621.29 | 46% |
Others | 4 | $108.05 | 8% |
Igor Tomasz Kowalkiewicz and Pola Alicja Kowalkiewicz hold a combined 92% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 15, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | STAROSTA POWIATU KOŁOBRZESKIEGO |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Ms-Pharmsp. z o.o. + limited partnership | $4,619,501.46 | mspharm.pl | ||
| Eurekasp. z o.o. | $1,377,733.77 | fundacja-eureka.edu.pl | ||
| Farmacja Im. O. Klimuszkisp. z o.o. | $1,289,548.20 | zyj-zdrowo.com | ||
| Twoja Tania Apteka Farmarsp. z o.o. | $440,843.57 | domlekow.pl | ||
| Nukloversp. z o.o. | $227,479.26 | nuklover.com | ||
| Massmedsp. z o.o. | $49,747.70 | mojoapps.co | ||
| Pharmer Polskasp. z o.o. | $15,884.06 | punktapteczny.online | ||
| DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A. | $2,740.83 | kwendasa.pl | ||
| Femaherbsp. z o.o. | $655.76 | femaherb.com | ||
| Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-SzczecinS.A. | – | farmacol.com.pl |
FAQ
The main business activity of Medipharma focuses on dispensing chemist in specialised stores.
The company was registered in the Polish National Court Register (KRS) on July 1, 2015.
The headquarters is located at: ul. Aleksandra Fredry 9B, 78-100 Kołobrzeg.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $176,876, representing a decrease of 4.0% compared to 2023.
Yes, the company recorded a net profit of $105,027 in 2024, meaning the company decreased its profit by 12.2%.
The largest operating cost category falls under employee remuneration. This category amounted to $32,101 in 2024, representing 54% of all operating expenses.
Last updated: 2026-07-30